Journal article
Quality of Life of Stereotactic vs. Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results from the XXXXXX trial
Abstract
BACKGROUND: There is limited evidence on quality of life (QoL) outcomes of stereotactic body radiotherapy (SBRT) compared with conventionally hypofractionated radiotherapy (CHRT) in patients with medically inoperable stage I (≤5 cm) non-small cell lung cancer (NSCLC).
METHODS: This phase 3 randomized trial was conducted across 16 Canadian centers, enrolling patients with medically inoperable stage I (≤5 cm) non-small cell lung cancer (NSCLC). …
Authors
Hou Q; Parpia S; Wierzbicki M; Kundapur V; Faria S; Okawara GS; Tsakiridis TK; Ahmed N; Bujold A; Hirmiz K
Journal
International Journal of Radiation Oncology • Biology • Physics, , ,
Publisher
Elsevier
Publication Date
11 2025
DOI
10.1016/j.ijrobp.2025.11.026
ISSN
0360-3016